Description | It is edited by our special CRISPR/Cas9 technology. |
Size | 1 vial (2*106 cells/vial) |
Parental Cell Line | 293T/17 cell line |
Biosafety Level | 1 |
Culture Condition | Cells are cultured as a suspension at 37°C in a humidified atmosphere with 5% CO2. Cells should be passaged every 3-5 days. |
Subculture Guidelines | The recommended seeding density is 2*104 cells/cm2. If necessary, a partial replacement of the medium 24 hours before subculture may help promote growth. When the cells achieve 80-90% confluence, they should be passaged. |
Knockout Validation | Sanger Sequencing |
Viability | >95% viability before freezing. |
Adherent /Suspension | Adherent |
Disease | Carcinoma |
Purity | Immunogen affinity purified |
Storage Buffer | Constituents: 8.7% Dimethylsulfoxide, 2% Cellulose, methyl ether |
Storage | Liquid Nitrogen |
Mycoplasma Free | Yes |
Application | For research use only |
Shipping Info | Dry Ice |
Quality Control | All cells test negative for bacteria, yeast, and fungi. |
Recommended Medium And Supplement | Growth Medium: IMDM, 10% FCS; Revival: Thaw cells quickly in a 37°C water bath. Transfer the contents to a tube filled with preheating medium. |
Freeze Medium | Freeze Medium: IMDM, 20% FCS, 10% DMSO |
Cell Revival | Revival: Rapidly thaw cells in a 37°C water bath. Transfer the contents to the tube containing the preheating medium. Centrifuge the cells and seeds into the pre-warmed medium in a 10 ml Petri dish. |
Species | Human |
Tissue | Kidney |
Recommended Control | Human wild-type 293T/17 cell line |
Product Type | Knockout Stable Cell Line |
Price | Inquiry |